DRNA insider filings

Dicerna Pharmaceuticals Inc — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2021-12-29. Screen DRNA transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for DRNA between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.

Recent insider filings — Dicerna Pharmaceuticals Inc

FiledFormInsiderReported transactionsSource
2021-12-294Zeng Ling — Chief Legal Officer & Sec'yCode (U): 5,032 @ $38.25 · Disposition to issuer (D): 7,688 (derivative) · Disposition to issuer (D): 13,669 (derivative) · Disposition to issuer (D): 81,825 (derivative) · Disposition to issuer (D): 46,120 (derivative)EDGAR
2021-12-294Weissman James B — Chief Operating Officer & EVPCode (U): 18,100 @ $38.25 · Disposition to issuer (D): 25,950 (derivative) · Disposition to issuer (D): 11,325 (derivative) · Disposition to issuer (D): 11,879 (derivative) · Disposition to issuer (D): 33,999 (derivative) · Disposition to issuer (D): 105,000 (derivative) · +5 moreEDGAR
2021-12-294Smith Cynthia — DirectorCode (U): 3,333 @ $38.25 · Disposition to issuer (D): 3,333 (derivative) · Disposition to issuer (D): 25,000 (derivative) · Disposition to issuer (D): 25,000 (derivative) · Disposition to issuer (D): 15,000 (derivative) · Disposition to issuer (D): 15,000 (derivative)EDGAR
2021-12-294Pagan Douglas W. — Chief Financial OfficerCode (U): 7,775 @ $38.25 · Disposition to issuer (D): 20,475 (derivative) · Disposition to issuer (D): 6,150 (derivative) · Disposition to issuer (D): 95,650 (derivative) · Disposition to issuer (D): 36,900 (derivative)EDGAR
2021-12-294GRAY PATRICK M. — DirectorCode (U): 3,333 @ $38.25 · Disposition to issuer (D): 3,333 (derivative) · Disposition to issuer (D): 25,000 (derivative) · Disposition to issuer (D): 15,000 (derivative) · Disposition to issuer (D): 15,000 (derivative)EDGAR
2021-12-294Freed Martin I — DirectorCode (U): 3,333 @ $38.25 · Disposition to issuer (D): 3,333 (derivative) · Disposition to issuer (D): 25,000 (derivative) · Disposition to issuer (D): 25,000 (derivative) · Disposition to issuer (D): 25,000 (derivative) · Disposition to issuer (D): 25,000 (derivative) · +2 moreEDGAR
2021-12-294Doberstein Stephen K — DirectorCode (U): 3,333 @ $38.25 · Disposition to issuer (D): 3,333 (derivative) · Disposition to issuer (D): 25,000 (derivative) · Disposition to issuer (D): 15,000 (derivative) · Disposition to issuer (D): 15,000 (derivative)EDGAR
2021-12-294Ciappenelli Robert D. — Chief Strategy OfficerCode (U): 14,813 @ $38.25 · Disposition to issuer (D): 10,275 (derivative) · Disposition to issuer (D): 17,325 (derivative) · Disposition to issuer (D): 270,000 (derivative) · Disposition to issuer (D): 76,144 (derivative) · Disposition to issuer (D): 61,500 (derivative)EDGAR
2021-12-294Brown Bob D — Chief Scientific Ofr., EVP R&DCode (U): 2,367 @ $38.25 · Disposition to issuer (D): 25,950 (derivative) · Disposition to issuer (D): 11,325 (derivative) · Disposition to issuer (D): 85,000 (derivative) · Disposition to issuer (D): 105,000 (derivative) · Disposition to issuer (D): 180,000 (derivative) · +4 moreEDGAR
2021-12-294Aradhye Shreeram — EVP & Chief Medical OfficerCode (U): 6,973 @ $38.25 · Disposition to issuer (D): 21,075 (derivative) · Disposition to issuer (D): 8,513 (derivative) · Disposition to issuer (D): 124,700 (derivative) · Disposition to issuer (D): 51,070 (derivative)EDGAR
2021-12-294Koppel Adam — DirectorCode (U): 3,333 @ $38.25 · Code (U): 3,080,237 @ $38.25 · Disposition to issuer (D): 3,333 (derivative) · Disposition to issuer (D): 25,000 (derivative) · Disposition to issuer (D): 25,000 (derivative) · Disposition to issuer (D): 25,000 (derivative) · +3 moreEDGAR
2021-12-294FAMBROUGH DOUGLAS — Chief Executive Officer, DirectorDisposition to issuer (D): 231,431 @ $38.25 · Disposition to issuer (D): 59,850 (derivative) · Disposition to issuer (D): 41,250 (derivative) · Disposition to issuer (D): 191,330 (derivative) · Disposition to issuer (D): 281,250 (derivative) · Disposition to issuer (D): 55,055 (derivative) · +9 moreEDGAR
2021-12-294KOZIN MARC D — DirectorDisposition to issuer (D): 6,333 @ $38.25 · Disposition to issuer (D): 5,000 @ $38.25 · Disposition to issuer (D): 3,333 (derivative) · Disposition to issuer (D): 25,000 (derivative) · Disposition to issuer (D): 25,000 (derivative) · Disposition to issuer (D): 15,000 (derivative) · +1 moreEDGAR
2021-12-294BUCHI J KEVIN — DirectorCode (U): 4,666 @ $38.25 · Disposition to issuer (D): 3,333 (derivative) · Disposition to issuer (D): 8,000 (derivative) · Disposition to issuer (D): 25,000 (derivative) · Disposition to issuer (D): 33,000 (derivative) · Disposition to issuer (D): 21,000 (derivative) · +1 moreEDGAR
2021-12-294HOFFMAN STEPHEN J — DirectorCode (U): 16,157 @ $38.25 · Disposition to issuer (D): 3,333 (derivative) · Disposition to issuer (D): 15,000 (derivative) · Disposition to issuer (D): 25,000 (derivative) · Disposition to issuer (D): 25,000 (derivative) · Disposition to issuer (D): 15,000 (derivative) · +5 moreEDGAR
2021-12-174Pagan Douglas W. — Chief Financial OfficerOption exercise (M): 2,050 · Tax withholding (F): 602 @ $38.05 · Option exercise (M): 2,050 (derivative) @ $0EDGAR
2021-12-174Ciappenelli Robert D. — Chief Strategy OfficerOption exercise (M): 3,425 · Tax withholding (F): 1,241 @ $38.05 · Option exercise (M): 3,425 (derivative) @ $0EDGAR
2021-12-174Aradhye Shreeram — EVP & Chief Medical OfficerOption exercise (M): 2,837 · Tax withholding (F): 833 @ $38.05 · Option exercise (M): 2,837 (derivative) @ $0EDGAR
2021-12-174Weissman James B — Chief Operating Officer & EVPOption exercise (M): 3,775 · Tax withholding (F): 1,675 @ $38.05 · Option exercise (M): 3,775 (derivative) @ $0EDGAR
2021-12-174Brown Bob D — Chief Scientific Ofr., EVP R&DOption exercise (M): 3,775 · Tax withholding (F): 1,675 @ $38.05 · Option exercise (M): 3,775 (derivative) @ $0EDGAR
2021-12-174Zeng Ling — Chief Legal Officer & Sec'yOption exercise (M): 2,562 · Tax withholding (F): 752 @ $38.05 · Option exercise (M): 2,562 (derivative) @ $0EDGAR
2021-12-174FAMBROUGH DOUGLAS — Chief Executive Officer, DirectorOption exercise (M): 13,750 · Tax withholding (F): 5,348 @ $38.05 · Option exercise (M): 13,750 (derivative) @ $0EDGAR
2021-12-144Ciappenelli Robert D. — Chief Strategy OfficerOption exercise (M): 8,856 @ $22.58 · Option exercise (M): 8,856 (derivative) @ $0EDGAR
2021-12-134FAMBROUGH DOUGLAS — Chief Executive Officer, DirectorOption exercise (M): 33,670 @ $2.97 · Option exercise (M): 146,195 @ $3.42 · Option exercise (M): 33,670 (derivative) @ $0 · Option exercise (M): 146,195 (derivative) @ $0EDGAR
2021-11-224Brown Bob D — Chief Scientific Ofr., EVP R&DOption exercise (M): 24,936 @ $3.42 · Sale (S): 24,936 @ $37.94 · Option exercise (M): 24,936 (derivative) @ $0EDGAR
2021-09-214Brown Bob D — Chief Scientific Ofr., EVP R&DSale (S): 21,250 @ $21.06EDGAR
2021-09-174Zeng Ling — Chief Legal Officer & Sec'yOption exercise (M): 4,556 · Sale (S): 1,334 @ $21.47 · Option exercise (M): 4,556 (derivative) @ $0EDGAR
2021-09-174Aradhye Shreeram — EVP & Chief Medical OfficerOption exercise (M): 7,025 · Sale (S): 2,056 @ $21.47 · Option exercise (M): 7,025 (derivative) @ $0EDGAR
2021-08-104FAMBROUGH DOUGLAS — President and CEO, DirectorPurchase (P): 5,000 @ $22.10EDGAR
2021-08-104KOZIN MARC D — DirectorPurchase (P): 3,000 @ $23.66EDGAR
2021-08-034Brown Bob D — Chief Scientific Ofr., EVP R&DOption exercise (M): 8,312 @ $3.42 · Sale (S): 8,312 @ $37.38 · Option exercise (M): 8,312 (derivative) @ $0EDGAR
2021-07-084Paglia Regina M. — Chief Human Resources OfficerOption exercise (M): 1,450 · Option exercise (M): 1,712 · Tax withholding (F): 1,404 @ $37.05 · Option exercise (M): 1,450 (derivative) @ $0 · Option exercise (M): 1,712 (derivative) @ $0EDGAR
2021-07-084Weissman James B — Chief Operating Officer & EVPOption exercise (M): 30,000 @ $9.09 · Sale (S): 30,000 @ $39.09 · Option exercise (M): 30,000 (derivative) @ $0EDGAR
2021-07-064Brown Bob D — Chief Scientific Ofr., EVP R&DOption exercise (M): 8,312 @ $3.42 · Sale (S): 7,246 @ $37.30 · Sale (S): 1,066 @ $37.85 · Option exercise (M): 8,312 (derivative) @ $0EDGAR
2021-06-294Paglia Regina M. — Chief Human Resources OfficerOption exercise (M): 1,000 @ $22.58 · Sale (S): 1,000 @ $38.00 · Option exercise (M): 1,000 (derivative) @ $0EDGAR
2021-06-244Paglia Regina M. — Chief Human Resources OfficerOption exercise (M): 13,750 @ $12.93 · Option exercise (M): 2,279 @ $22.58 · Option exercise (M): 2,406 @ $24.05 · Sale (S): 13,555 @ $37.10 · Sale (S): 4,880 @ $36.71 · Option exercise (M): 13,750 (derivative) @ $0 · +2 moreEDGAR
2021-06-224Paglia Regina M. — Chief Human Resources OfficerOption exercise (M): 4,664 @ $12.93 · Option exercise (M): 4,000 @ $24.05 · Sale (S): 8,664 @ $35.79 · Option exercise (M): 4,664 (derivative) @ $0 · Option exercise (M): 4,000 (derivative) @ $0EDGAR
2021-06-174Pagan Douglas W. — Chief Financial OfficerOption exercise (M): 6,825 · Tax withholding (F): 2,004 @ $35.74 · Option exercise (M): 6,825 (derivative) @ $0EDGAR
2021-06-174Paglia Regina M. — Chief Human Resources OfficerOption exercise (M): 381 · Tax withholding (F): 112 @ $35.74 · Option exercise (M): 20,000 @ $12.93 · Option exercise (M): 10,000 @ $22.58 · Option exercise (M): 1,564 @ $26.62 · Sale (S): 31,464 @ $35.63 · +5 moreEDGAR
2021-06-154Brown Bob D — Chief Scientific Ofr., EVP R&DOption exercise (M): 10,000 @ $9.09 · Sale (S): 10,000 @ $34 · Option exercise (M): 10,000 (derivative) @ $0EDGAR
2021-06-154Ciappenelli Robert D. — Chief Commercial OfficerOption exercise (M): 10,000 @ $15.61 · Sale (S): 10,000 @ $35 · Option exercise (M): 20,000 @ $15.61 · Sale (S): 20,000 @ $38 · Option exercise (M): 10,000 (derivative) @ $0 · Option exercise (M): 20,000 (derivative) @ $0EDGAR
2021-06-084Brown Bob D — Chief Scientific Ofr., EVP R&DOption exercise (M): 10,000 @ $9.09 · Sale (S): 10,000 @ $33 · Option exercise (M): 10,000 (derivative) @ $0EDGAR
2021-06-074Freed Martin I — DirectorOption exercise (M): 3,333 · Option exercise (M): 3,333 (derivative) @ $0 · Grant/award (A): 3,333 (derivative) @ $0 · Grant/award (A): 15,000 (derivative) @ $0EDGAR
2021-06-074GRAY PATRICK M. — DirectorOption exercise (M): 3,333 · Option exercise (M): 3,333 (derivative) @ $0 · Grant/award (A): 3,333 (derivative) @ $0 · Grant/award (A): 15,000 (derivative) @ $0EDGAR
2021-06-074Doberstein Stephen K — DirectorOption exercise (M): 3,333 · Option exercise (M): 3,333 (derivative) @ $0 · Grant/award (A): 3,333 (derivative) @ $0 · Grant/award (A): 15,000 (derivative) @ $0EDGAR
2021-06-074Koppel Adam — DirectorOption exercise (M): 3,333 @ $0 · Option exercise (M): 3,333 (derivative) @ $0 · Grant/award (A): 3,333 (derivative) @ $0 · Grant/award (A): 15,000 (derivative) @ $0EDGAR
2021-06-074Protopapas Anna — DirectorOption exercise (M): 3,333 · Option exercise (M): 3,333 (derivative) @ $0EDGAR
2021-06-074KOZIN MARC D — DirectorOption exercise (M): 3,333 · Option exercise (M): 3,333 (derivative) @ $0 · Grant/award (A): 3,333 (derivative) @ $0 · Grant/award (A): 15,000 (derivative) @ $0EDGAR
2021-06-074BUCHI J KEVIN — DirectorOption exercise (M): 4,666 · Option exercise (M): 4,666 (derivative) @ $0 · Grant/award (A): 3,333 (derivative) @ $0 · Grant/award (A): 15,000 (derivative) @ $0EDGAR
2021-06-074HOFFMAN STEPHEN J — DirectorOption exercise (M): 3,333 · Option exercise (M): 3,333 (derivative) @ $0 · Grant/award (A): 3,333 (derivative) @ $0 · Grant/award (A): 15,000 (derivative) @ $0EDGAR

Recent 8-K events — Dicerna Pharmaceuticals Inc

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2021-12-288-K2.01 — Completion of Acquisition or Disposition of Assets
3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
3.03 — Material Modification to Rights of Security Holders
5.01 — Changes in Control of Registrant
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2021-11-188-K1.01 — Entry into a Material Definitive Agreement
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2021-11-098-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2021-08-098-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2021-08-068-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2021-06-048-K5.07 — Submission of Matters to a Vote of Security Holders
9.01 — Financial Statements and Exhibits
EDGAR
2021-05-068-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2021-04-128-K1.01 — Entry into a Material Definitive Agreement
9.01 — Financial Statements and Exhibits
EDGAR
2021-03-128-K5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
9.01 — Financial Statements and Exhibits
EDGAR
2021-03-028-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=DRNA returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs